ZEKE CAPITAL ADVISORS, LLC - VALLON PHARMACEUTICALS INC ownership

VALLON PHARMACEUTICALS INC's ticker is VLON and the CUSIP is 92023M101. A total of 12 filers reported holding VALLON PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ZEKE CAPITAL ADVISORS, LLC ownership history of VALLON PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$28,000
-68.9%
15,0000.0%0.00%
-80.0%
Q4 2021$90,000
-37.9%
15,000
-25.0%
0.01%
-37.5%
Q3 2021$145,000
-11.0%
20,000
-33.3%
0.01%
-20.0%
Q2 2021$163,00030,0000.01%
Other shareholders
VALLON PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Ikarian Capital, LLC 198,085$1,184,0000.18%
Laidlaw Wealth Management LLC 20,200$121,0000.02%
ZEKE CAPITAL ADVISORS, LLC 15,000$90,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 21,250$127,0000.00%
OSAIC HOLDINGS, INC. 5,533$33,0000.00%
WELLS FARGO & COMPANY/MN 14$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 17,841$106,0000.00%
STATE STREET CORP 11,200$67,0000.00%
MORGAN STANLEY 2,628$16,0000.00%
View complete list of VALLON PHARMACEUTICALS INC shareholders